According to the FDA, a biosimilar is a biologic that is highly similar to another biologic that has been approved by the FDA. A biosimilar can’t have any clinically meaningful differences from its original biologic (often referred to as the reference product) and must have the same route of administration, the same strength/dosage form, and the same potential side effects. Read More >
